Home
.
Site map
.
Contact us
.
Disclaimer
.
Privacy policy
About Peplin
Company profile
Company history
Corporate strategy
Products & technology
Research and development
Drug development process
Clinical development
Pre-clinical development
Research
Research programs
Publications
Abstracts
Manufacturing process
Glossary
Target diseases
Actinic keratosis (AK)
Non-melanoma skin cancer (NMSC)
Leukemia
Bladder cancer
Corporate information
Board of directors
Executive management
Corporate directory
Corporate governance
Dermatology clinical advisory board
Investor information
ASX & media releases
PEPTalk
Reports to shareholders
Annual
Half yearly
Quarterly cashflow
Share price information
Securities trading
Major shareholders
FAQs
Links
News reports
Corporate governance
.................................................................................
Certificate of Incorporation
30 Kb
By-laws
189 Kb
Charter of the Audit Committee
131 Kb
Charter of the Compensation Committee
86 Kb
Charter of the Nominating & Corporate Governance Committee
75 Kb
Corporate Governance Guidelines
44 Kb
Code of Business Conduct and Ethics
141 Kb
click
here
to download the Adobe reader
© Peplin 2008